These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 16830791)
1. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA. Gao P; Zhou GY; Zhang QH; Li H; Mu K; Yuan YP; Zhang J; Wang BH Chin J Physiol; 2006 Apr; 49(2):96-103. PubMed ID: 16830791 [TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites. Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143 [TBL] [Abstract][Full Text] [Related]
3. [Reversal of multidrug resistance of tumor cells by anti-mdr1 ribozyme]. Gao P; Zhou GY; Zhang QH; Zhou CJ; Zhen JH; Sun YL Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):251-4. PubMed ID: 15256119 [TBL] [Abstract][Full Text] [Related]
4. Reversion of multidrug resistance in the P-glycoprotein positive breast cancer cell line (MCF-7/ADR) by introduction of hammerhead ribozyme. Yuan Y; Zhang J; Scanlon KJ; Lu Z; Qi G Chin Med Sci J; 1998 Mar; 13(1):24-8. PubMed ID: 11717919 [TBL] [Abstract][Full Text] [Related]
5. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter. Gao P; Zhou GY; Guo LL; Zhang QH; Zhen JH; Fang AJ; Lin XY Cancer Lett; 2007 Oct; 256(1):81-9. PubMed ID: 17637500 [TBL] [Abstract][Full Text] [Related]
6. Restoration of chemosensitivity in cancer cells with MDR phenotype by deoxyribozyme, compared with ribozyme. Xing AY; Shi DB; Liu W; Chen X; Sun YL; Wang X; Zhang JP; Gao P Exp Mol Pathol; 2013 Jun; 94(3):481-5. PubMed ID: 23531420 [TBL] [Abstract][Full Text] [Related]
7. Functional study of the novel multidrug resistance gene HA117 and its comparison to multidrug resistance gene 1. Zhao L; Jin X; Xu Y; Guo Y; Liang R; Guo Z; Chen T; Sun Y; Ding X J Exp Clin Cancer Res; 2010 Jul; 29(1):98. PubMed ID: 20642825 [TBL] [Abstract][Full Text] [Related]
8. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
9. Co-suppression of MDR1 (multidrug resistance 1) and GCS (glucosylceramide synthase) restores sensitivity to multidrug resistance breast cancer cells by RNA interference (RNAi). Zhang X; Li J; Qiu Z; Gao P; Wu X; Zhou G Cancer Biol Ther; 2009 Jun; 8(12):1117-21. PubMed ID: 19502811 [TBL] [Abstract][Full Text] [Related]
10. Selection of antisense oligonucleotides for reversal of multidrug resistance in breast carcinoma cells. Gao P; Zhou GY; Lei DP; Zhang XF; Li L; Xu JW; Lin XY Cytotherapy; 2007; 9(8):795-801. PubMed ID: 17917879 [TBL] [Abstract][Full Text] [Related]
11. Effect of phosphatase and tensin homology deleted on chromosome 10 (PTEN) gene transfection on reversal of multidrug resistance in K562/ADM cells. Cheng Z; Yang N; Liang W; Yan X; Li L; Pan L Leuk Lymphoma; 2012 Jul; 53(7):1383-9. PubMed ID: 22185283 [TBL] [Abstract][Full Text] [Related]
12. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells. Eijdems EW; Zaman GJ; de Haas M; Versantvoort CH; Flens MJ; Scheper RJ; Kamst E; Borst P; Baas F Br J Cancer; 1995 Aug; 72(2):298-306. PubMed ID: 7640209 [TBL] [Abstract][Full Text] [Related]
13. Screening of deoxyribozyme with high reversal efficiency against multidrug resistance in breast carcinoma cells. Gao P; Wei JM; Li PY; Zhang CJ; Jian WC; Zhang YH; Xing AY; Zhou GY J Cell Mol Med; 2011 Oct; 15(10):2130-8. PubMed ID: 21155975 [TBL] [Abstract][Full Text] [Related]
14. Reversal of HCC drug resistance by using hammerhead ribozymes against multidrug resistance 1 gene. Qia S; Wang H; Chen X J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):662-4. PubMed ID: 16696319 [TBL] [Abstract][Full Text] [Related]
15. Reversal of multi-drug resistance by pSUPER-shRNA-mdr1 in vivo and in vitro. Pan GD; Yang JQ; Yan LN; Chu GP; Liu Q; Xiao Y; Yuan L World J Gastroenterol; 2009 Jan; 15(4):431-40. PubMed ID: 19152447 [TBL] [Abstract][Full Text] [Related]
16. Reversal of multi-drug resistance by vector-based-shRNA-mdr1 in vitro and in vivo. Lu S; Huang Q; Wang Z; Song Y; Wang L J Huazhong Univ Sci Technolog Med Sci; 2009 Oct; 29(5):620-4. PubMed ID: 19821097 [TBL] [Abstract][Full Text] [Related]
17. Overcoming multi-drug resistance by anti-MDR1 ribozyme. Wang H; Chen XP; Qiu FZ World J Gastroenterol; 2003 Jul; 9(7):1444-9. PubMed ID: 12854138 [TBL] [Abstract][Full Text] [Related]
18. Relation between MDR1 mRNA levels, resistance factor, and the efficiency of P-glycoprotein-mediated efflux of pirarubicin in multidrug-resistant K562 sublines. Meesungnoen J; Jay-Gerin JP; Mankhetkorn S Can J Physiol Pharmacol; 2002 Nov; 80(11):1054-63. PubMed ID: 12489924 [TBL] [Abstract][Full Text] [Related]
19. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics. Kobayashi H; Takemura Y; Miyachi H Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737 [TBL] [Abstract][Full Text] [Related]
20. Effect of fractionated irradiation on the expression of multidrug resistance genes in the CNE1 human nasopharyngeal carcinoma cell line. Ji XN; Yang F; Sui XM; Wang FG; Ge RG; Quan XL; Zhao T; Gao BW; Wang RY Mol Med Rep; 2013 Jan; 7(1):187-94. PubMed ID: 23128850 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]